These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32248003)

  • 1. Discovery of new LXRβ agonists as glioblastoma inhibitors.
    Chen H; Chen Z; Zhang Z; Li Y; Zhang S; Jiang F; Wei J; Ding P; Zhou H; Gu Q; Xu J
    Eur J Med Chem; 2020 May; 194():112240. PubMed ID: 32248003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of new thiazolo-pyrrolidine-(spirooxindole) tethered to 3-acylindole as anticancer agents.
    Islam MS; Ghawas HM; El-Senduny FF; Al-Majid AM; Elshaier YAMM; Badria FA; Barakat A
    Bioorg Chem; 2019 Feb; 82():423-430. PubMed ID: 30508794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of Spiro[pyrrolidine-3,3'-oxindole] LXRβ Agonists for the Treatment of Osteoporosis.
    Chen H; Hua P; Huang D; Zhang Y; Zhou H; Xu J; Gu Q
    J Med Chem; 2023 Jan; 66(1):752-765. PubMed ID: 36539349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spiro[pyrrolidine-3,3'-oxindoles] and Their Indoline Analogues as New 5-HT6 Receptor Chemotypes.
    Kelemen ÁA; Satala G; Bojarski AJ; Keserű GM
    Molecules; 2017 Dec; 22(12):. PubMed ID: 29240714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined Scaffold Evaluation and Systems-Level Transcriptome-Based Analysis for Accelerated Lead Optimization Reveals Ribosomal Targeting Spirooxindole Cyclopropanes.
    Rodriguez KX; Howe EN; Bacher EP; Burnette M; Meloche JL; Meisel J; Schnepp P; Tan X; Chang M; Zartman J; Zhang S; Ashfeld BL
    ChemMedChem; 2019 Sep; 14(18):1653-1661. PubMed ID: 31140738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and biological evaluation of nitroisoxazole-containing spiro[pyrrolidin-oxindole] derivatives as novel glutathione peroxidase 4/mouse double minute 2 dual inhibitors that inhibit breast adenocarcinoma cell proliferation.
    Liu SJ; Zhao Q; Peng C; Mao Q; Wu F; Zhang FH; Feng QS; He G; Han B
    Eur J Med Chem; 2021 May; 217():113359. PubMed ID: 33725632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereoselective synthesis and discovery of novel spirooxindolopyrrolidine engrafted indandione heterocyclic hybrids as antimycobacterial agents.
    Arumugam N; Almansour AI; Kumar RS; Siva Krishna V; Sriram D; Dege N
    Bioorg Chem; 2021 May; 110():104798. PubMed ID: 33735710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positioning of an unprecedented 1,5-oxaza spiroquinone scaffold into SMYD2 inhibitors in epigenetic space.
    Dhorma LP; Teli MK; Nangunuri BG; Venkanna A; Ragam R; Maturi A; Mirzaei A; Vo DK; Maeng HJ; Kim MH
    Eur J Med Chem; 2022 Jan; 227():113880. PubMed ID: 34656041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of pyrrole derivatives for the treatment of glioblastoma and chronic myeloid leukemia.
    Puxeddu M; Shen H; Bai R; Coluccia A; Bufano M; Nalli M; Sebastiani J; Brancaccio D; Da Pozzo E; Tremolanti C; Martini C; Orlando V; Biagioni S; Sinicropi MS; Ceramella J; Iacopetta D; Coluccia AML; Hamel E; Liu T; Silvestri R; La Regina G
    Eur J Med Chem; 2021 Oct; 221():113532. PubMed ID: 34052717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, Synthesis and Antitumor Activity of Novel Dispiro[oxindole-cyclohexanone]- pyrrolidines.
    Gouda M; Bawazeer M; Hegazy L; Azab M; Elagawany M; Rateb M; Yaseen M; Elgendy B
    Curr Pharm Des; 2022; 28(3):198-207. PubMed ID: 34176458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of novel liver X receptor inverse agonists as lipogenesis inhibitors.
    Chen Z; Chen H; Zhang Z; Ding P; Yan X; Li Y; Zhang S; Gu Q; Zhou H; Xu J
    Eur J Med Chem; 2020 Nov; 206():112793. PubMed ID: 32961480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and Biological Evaluation of Pyrazoline and Pyrrolidine-2,5-dione Hybrids as Potential Antitumor Agents.
    Tilekar K; Upadhyay N; Meyer-Almes FJ; Loiodice F; Anisimova NY; Spirina TS; Sokolova DV; Smirnova GB; Choe JY; Pokrovsky VS; Lavecchia A; S Ramaa C
    ChemMedChem; 2020 Oct; 15(19):1813-1825. PubMed ID: 32715626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploiting the antiproliferative potential of spiropyrazoline oxindoles in a human ovarian cancer cell line.
    Raposo LR; Silva A; Silva D; Roma-Rodrigues C; Espadinha M; Baptista PV; Santos MMM; Fernandes AR
    Bioorg Med Chem; 2021 Jan; 30():115880. PubMed ID: 33348171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fe
    Maddela S; Makula A; Galigniana MD; Parambi DGT; Federicci F; Mazaira G; Hendawy OM; Dev S; Mathew GE; Mathew B
    Arch Pharm (Weinheim); 2019 Jan; 352(1):e1800174. PubMed ID: 30485473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of spiro-tetrahydrothiopyran-oxindoles by Michael-aldol cascade reactions: discovery of potential P53-MDM2 inhibitors with good antitumor activity.
    Wang S; Chen S; Guo Z; He S; Zhang F; Liu X; Chen W; Zhang S; Sheng C
    Org Biomol Chem; 2018 Jan; 16(4):625-634. PubMed ID: 29302672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, antidiabetic activity and molecular docking study of rhodanine-substitued spirooxindole pyrrolidine derivatives as novel α-amylase inhibitors.
    Toumi A; Boudriga S; Hamden K; Sobeh M; Cheurfa M; Askri M; Knorr M; Strohmann C; Brieger L
    Bioorg Chem; 2021 Jan; 106():104507. PubMed ID: 33288322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reliability of Click Chemistry on Drug Discovery: A Personal Account.
    Shankaraiah N; Sakla AP; Laxmikeshav K; Tokala R
    Chem Rec; 2020 Apr; 20(4):253-272. PubMed ID: 31419056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Tetrachlorophthalimides as Liver X Receptor β (LXRβ)-Selective Agonists.
    Nomura S; Endo-Umeda K; Makishima M; Hashimoto Y; Ishikawa M
    ChemMedChem; 2016 Oct; 11(20):2347-2360. PubMed ID: 27690261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel piperazine based benzamide derivatives as potential anti-glioblastoma agents inhibiting cell proliferation and cell cycle progression.
    Lu Y; Feng Y; Li Z; Li J; Zhang H; Hu X; Jiang W; Shi T; Wang Z
    Eur J Med Chem; 2022 Jan; 227():113908. PubMed ID: 34656900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor properties of certain spirooxindoles towards hepatocellular carcinoma endowed with antioxidant activity.
    Al-Rashood ST; Hamed AR; Hassan GS; Alkahtani HM; Almehizia AA; Alharbi A; Al-Sanea MM; Eldehna WM
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):831-839. PubMed ID: 32208781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.